MINAPHARM ranks among the leading pharmaceutical companies in Egypt and the Middle East. The company maintains one of the broadest quality-products portfolio within the industry. Their longstanding expertise covers a broad spectrum of medicines, ranging from small molecules to extremely complex bioengineered proteins. Minapharm is leading a transition towards high-value biologicals in developing markets, while expanding a robust small-molecule setup in a business model that represents a far departure from existing regional models. In addition to production of life-saving and life-enhancing medicines, MINAPHARM is adopting an international operation platform for biotechnology and cellular engineering. Novel scientific solutions and technologies contribute to the development of products that were unimaginable a decade ago. Scientific excellence and expertise in cellular and bioprocess engineering enable the companies mission to provide not only developed markets, but also emerging markets with significant economic molecules, thus striking the next frontier. MINAPHARM is constantly demonstrating its ability to achieve the balance between Innovation and Affordability, hence, facing the most complex challenges of unmet medical needs in emerging countries.
Contact
El-Bardissi St., 2T Takseem Asmaa Fahmy St., Heliopolis, Cairo – Egypt.
(+202) 2414-3170/1/2/3/4/5
(+202) 2414-3179
All the latest news stories from Egypt’s healthcare and life sciences industry, including Egypt’s health insurance authority’s plans to add 100 new medical services, how the COVID-19 Omicron variant threatens…
As of today, the Evergreen boat that blocked global shipping when it got stuck in the Suez Canal has still not been allowed to leave Egypt. The infamous episode illustrated…
As Egypt rolls out Universal Health Insurance with the aim of achieving full coverage between 2030 and 2035, the domestic pharmaceutical market stands to see significant long-term shifts. As self-medication…
Amro Kandil, managing director Northeast Africa for GE Healthcare, outlines how his affiliate has grown to be the partner of choice for the Egyptian government as it seeks to improve…
As one of the longest-standing multinational companies in Egypt, French pharmaceutical giant Sanofi aims to plays a major role in ensuring access to innovative pharmaceuticals for the Egyptian population through…
Dr Mohsen Shalaby of Nerhadou International explains how he built Egypt’s leading mineral supplement and nutraceuticals company from scratch within 25 years, highlighting innovative solutions and the company’s aspirations to…
In our latest Healthcare & Life Sciences Review, we look at Egypt. With a swathe of economic reforms in the pipeline, including the launch of the Universal Healthcare Act, which…
Egypt has seen a decade of great transformation, from political instability and uncertainty to its current relative stability. Healthcare reform now stands near the top of the government’s agenda and…
Khaled Atef Elmounayri, country manager of AstraZeneca Egypt, reveals how AstraZeneca has remained the fastest-growing multinational pharmaceutical company for five years straight in Egypt, despite facing economic difficulties and pricing…
Dr Hany Mashaal, general manager for Egypt and the Rest of Middle East for Sun Pharma, explains the importance of Egypt for the Indian company, having recently opened a manufacturing…
Amre Mamdouh, vice president & area general manager for Egypt and North Africa at GSK, explains how GSK has been able to hold its leadership position in Egypt despite economic…
Dr Mohamed Khattab, the newly appointed chairman and managing director of Sedico, lifts the lid on his vision for the company being a leader in biotechnology and oncology in Egypt.…
See our Cookie Privacy Policy Here
